Trial Profile

Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 04 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BTRX 246040 (Primary)
Indications Anxiety; Major depressive disorder
Focus Therapeutic Use

Most Recent Events

28 Nov 2023 Status changed from recruiting to active, no longer recruiting.
03 Nov 2022 Status changed from not yet recruiting to recruiting.
31 Jan 2022 Planned initiation date changed from 15 Jan 2021 to 1 Oct 2022.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com